Upcoming InvestmentsDisney’s Free Cash Flow Faces Pressure: Can Higher Investment Pay Off?2 weeks agoThe Walt Disney Company DIS is facing free cash flow pressure as higher investment in its Experiences business and other...
Stock MarketThe Best “Strong Buy” Momentum Stocks to Buy Now in September3 weeks agoThe stock market cooled off a bit to start the Labor Day-shortened trading week, with the S&P 500 and the...
Stock MarketShould Investors Buy FET Stock After Its Massive 207% One-Year Run?4 weeks agoForum Energy Technologies, Inc. FET is a global manufacturer of engineered equipment and consumable products for the oil and gas, defense...
Stock MarketShould Investors Buy FET Stock After Its Massive 207% One-Year Run?4 weeks agoForum Energy Technologies, Inc. FET is a global manufacturer of engineered equipment and consumable products for the oil and gas, defense...
Stock Market5 Top-Ranked Growth Stocks to Strengthen Your Portfolio in September4 weeks agoU.S. stock markets ended on a positive note in August after mixed June and July. The astonishing bull run of...
Upcoming InvestmentsCan SR’s Strategic Investments Support Sustainable Long-Term Growth?4 weeks agoSpire Inc. SR benefits from its strategic capital investment plan by directing resources toward gas utility infrastructure, system upgrades and...
Stock MarketShould Invesco S&P SmallCap Value with Momentum ETF (XSVM) Be on Your Investing Radar?4 weeks agoThe Invesco S&P SmallCap Value with Momentum ETF (XSVM) was launched on March 3, 2005, and is a passively managed...
Upcoming InvestmentsCan SR’s Strategic Investments Support Sustainable Long-Term Growth?4 weeks agoSpire Inc. SR benefits from its strategic capital investment plan by directing resources toward gas utility infrastructure, system upgrades and...
Upcoming InvestmentsCan XEL’s Strategic Capital Investments Drive Long-Term Growth?1 month agoXcel Energy XEL benefits from strategic capital investments that modernize infrastructure, improve grid reliability and support clean energy goals. These...
CurrenciesRoche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum2 months agoSwiss pharma giant Roche Holding AG RHHBY reported sales of CHF 30.4 billion ($38.6 billion) in the first half of...